In vitro permeability through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transporter system

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 120-123

  Chong, Saeho ^a   Dando, Sandra A ^a   Soucek, Kathleen M ^a   Morrison, Richard A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ATENOLOL; CAFFEINE; CEFALEXIN; CERANAPRIL; GUANABENZ; LISINOPRIL; MACROGOL 4000; MANNITOL; NADOLOL; PRAVASTATIN; PROPRANOLOL; SALICYLIC ACID;

ARTICLE; CELL MEMBRANE PERMEABILITY; COLON CARCINOMA; DIFFUSION; DRUG ABSORPTION; DRUG TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CACO-2 CELLS; CARRIER PROTEINS; CELL MEMBRANE PERMEABILITY; DIFFUSION; DIPEPTIDES; HUMANS; INTESTINAL ABSORPTION; PEPTIDES; PREDICTIVE VALUE OF TESTS;

EID: 0029939330     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016045820933     Document Type: Article

References (17)

1. M. Pinto, S. Robine-Leon, M.D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assmann, K. Haffen, J. Fogh and A. Zweibaum. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47:323-330 (1983).
2. I.J. Hildago, T.J. Raub and R.T. Borchardt. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749 (1989).
3. A.H. Dantzig and L. Bergin. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta 1027:211-217 (1990).
4. K.-I. Inui, M. Yamamoto and H. Saito. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 261:195-201 (1992).
5. P. Artursson and J. Karlsson. Correlation between oral absorption in human and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Comm. 175:880-885 (1991).
6. D.I. Friedman and G.L. Amidon. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: Lisinopril and SQ 29852. J. Pharm. Sci. 78:995-998 (1989).
7. D.T. Thwaites, M. Cavet, B.H. Hirst and N.L. Simmons. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 114: 981-986 (1995)
8. A.H. Dantzig, J. Hoskins, L.B. Tabas, S. Bright, R.L. Shepard, I.L. Jenkins, D.C. Duckworth, J.R. Sportsman, D. Mackensen, P.R. Rosteck Jr. and P.L. Skatrud. Association of intestinal peptide transporter with a protein related to the cadherin superfamily. Science 264:430-433 (1994).
9. S.M. Singhvi, H.Y. Pan, R.A. Morrison, D.A. Willard. Disposition of parvastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br. J. Clin. Pharmac. 29:239-243 (1990).
10. J. Dreyfuss, L.J. Brannick, R.A. Vukovich, J.M. Shaw and D.A. Willard. Metabolic studies in patients with nadolol: oral and intravenous administration. J. Clin. Pharmacol. May-June, 300-307 (1977).
11. 14C-guanabenz in patients with essential hypertension. Clin. Pharmacol. Ther. 27:44-52 (1980).
12. D.W. Everett, S.J. Olsen, A.A. Sugerman, C. Ita, M.B. Stewart, J.W. Sherman and K.J. Kripalani. Disposition of SQ 32,756 (BV-araU) in healthy male subjects. Pharm. Res. 9:S316 (1992).
13. V. Marks and J.F. Kelly. Absorption of caffeine from tea, coffee and coca cola. Lancet 1:827 (1973).
14. G.M. Armayor and L.M. Lopez. Lisinopril: a new angiotensin-converting enzyme inhibitor. Drug Intel. Clin. Pharm. 22:365-372 (1988).
15. J. Foley, R. Morrison, S. Singhvi, J. Manning and D. Willard. The pharmacokinetics and pharmacodynamics of SQ 29,852, a new metabolically-stable phosphorus-containing angiotensin converting enzyme (ACE) inhibitor. Pharmacologists 30: 109.1 (1988).
16. P. Nicholas, B.R. Meyers and S.Z. Hirschman. Cephalexin: Pharmacologic evaluation following oral and parenteral administration. J. Clin. Pharmacol. November-December, 463-468 (1973).
17. H.C. Neu. Antimicrobial activity and human pharmacology of amoxicillin. J. Infect. Dis. 129: S123-S131 (1974).